Clinical Trial Update: Physiologic Phacofluidics: Ghost Protocol

View source ↗

Summary

The ClinicalTrials.gov entry for NCT06904404 reports that a trial evaluating physiologic phacofluidics (Ghost Protocol) for cataract surgery has completed and r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Snippet

Sponsor: Wolfe Eye Clinic | Conditions: Cataract | Status: COMPLETED | Results posted: 2025-08-12